Nicholas Teman
Concepts (356)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiac Surgical Procedures | 39 | 2024 | 501 | 12.200 |
Why?
| Extracorporeal Membrane Oxygenation | 17 | 2024 | 281 | 6.470 |
Why?
| Thoracic Surgery | 11 | 2025 | 133 | 5.350 |
Why?
| Coronary Artery Bypass | 10 | 2025 | 224 | 4.160 |
Why?
| Operating Rooms | 5 | 2024 | 109 | 3.240 |
Why?
| Surgeons | 10 | 2025 | 279 | 2.740 |
Why?
| Postoperative Complications | 32 | 2025 | 2494 | 2.620 |
Why?
| Pulmonary Embolism | 6 | 2024 | 211 | 2.300 |
Why?
| Heart-Assist Devices | 8 | 2024 | 529 | 2.160 |
Why?
| Intensive Care Units | 7 | 2024 | 730 | 2.130 |
Why?
| Retrospective Studies | 61 | 2025 | 14546 | 1.870 |
Why?
| Heart Arrest | 5 | 2024 | 327 | 1.790 |
Why?
| Airway Extubation | 3 | 2024 | 53 | 1.790 |
Why?
| Heart Valve Prosthesis Implantation | 8 | 2022 | 198 | 1.780 |
Why?
| Heart Transplantation | 7 | 2023 | 713 | 1.570 |
Why?
| Elective Surgical Procedures | 2 | 2024 | 164 | 1.560 |
Why?
| Cardiopulmonary Bypass | 5 | 2024 | 193 | 1.550 |
Why?
| Tricuspid Valve Insufficiency | 5 | 2020 | 26 | 1.510 |
Why?
| Sternotomy | 4 | 2022 | 24 | 1.420 |
Why?
| Treatment Outcome | 33 | 2024 | 10239 | 1.420 |
Why?
| Coronary Artery Disease | 6 | 2025 | 695 | 1.400 |
Why?
| Biomedical Research | 4 | 2025 | 654 | 1.290 |
Why?
| Humans | 104 | 2025 | 128896 | 1.220 |
Why?
| Failure to Rescue, Health Care | 2 | 2024 | 3 | 1.150 |
Why?
| Shock, Cardiogenic | 4 | 2024 | 61 | 1.130 |
Why?
| Hospital Mortality | 10 | 2024 | 853 | 1.120 |
Why?
| Internship and Residency | 7 | 2021 | 1052 | 1.090 |
Why?
| Heparin | 3 | 2023 | 252 | 1.060 |
Why?
| Clinical Competence | 6 | 2021 | 1020 | 1.030 |
Why?
| Heart Failure | 6 | 2022 | 2142 | 1.010 |
Why?
| Mitral Valve Insufficiency | 2 | 2018 | 79 | 0.990 |
Why?
| Aged | 36 | 2025 | 22035 | 0.980 |
Why?
| Middle Aged | 41 | 2025 | 30977 | 0.970 |
Why?
| Education, Medical, Graduate | 3 | 2019 | 436 | 0.970 |
Why?
| Myocardial Infarction | 3 | 2024 | 1031 | 0.960 |
Why?
| Catheters | 2 | 2016 | 67 | 0.950 |
Why?
| Advanced Cardiac Life Support | 1 | 2024 | 27 | 0.930 |
Why?
| Databases, Factual | 8 | 2024 | 1289 | 0.910 |
Why?
| Delirium | 2 | 2024 | 77 | 0.900 |
Why?
| Certification | 1 | 2024 | 93 | 0.880 |
Why?
| Hospital Costs | 3 | 2023 | 117 | 0.860 |
Why?
| Male | 53 | 2025 | 63146 | 0.830 |
Why?
| Critical Care | 4 | 2023 | 547 | 0.830 |
Why?
| Endovascular Procedures | 2 | 2020 | 304 | 0.830 |
Why?
| National Institutes of Health (U.S.) | 2 | 2020 | 122 | 0.820 |
Why?
| Prosthesis Design | 5 | 2022 | 321 | 0.810 |
Why?
| Thrombosis | 2 | 2023 | 331 | 0.810 |
Why?
| Ventricular Dysfunction, Right | 2 | 2022 | 226 | 0.800 |
Why?
| Length of Stay | 6 | 2022 | 1126 | 0.790 |
Why?
| Time Factors | 13 | 2024 | 6568 | 0.780 |
Why?
| Risk Factors | 20 | 2025 | 9792 | 0.780 |
Why?
| Sternum | 3 | 2023 | 25 | 0.780 |
Why?
| Subclavian Vein | 1 | 2021 | 15 | 0.770 |
Why?
| Device Removal | 2 | 2020 | 140 | 0.770 |
Why?
| Heart Valve Prosthesis | 3 | 2022 | 132 | 0.760 |
Why?
| Percutaneous Coronary Intervention | 3 | 2025 | 475 | 0.740 |
Why?
| Thrombectomy | 2 | 2022 | 58 | 0.720 |
Why?
| Registries | 6 | 2025 | 1916 | 0.710 |
Why?
| Aortic Valve | 5 | 2022 | 425 | 0.710 |
Why?
| Female | 48 | 2025 | 68162 | 0.710 |
Why?
| Ventricular Dysfunction | 1 | 2020 | 15 | 0.710 |
Why?
| Cost-Benefit Analysis | 3 | 2022 | 615 | 0.700 |
Why?
| Virginia | 6 | 2023 | 59 | 0.690 |
Why?
| Endocarditis, Bacterial | 1 | 2020 | 42 | 0.690 |
Why?
| Endocarditis | 1 | 2020 | 36 | 0.680 |
Why?
| Financing, Organized | 1 | 2020 | 34 | 0.680 |
Why?
| Catheterization, Central Venous | 1 | 2021 | 97 | 0.680 |
Why?
| Ventricular Outflow Obstruction | 1 | 2020 | 41 | 0.680 |
Why?
| Hemorrhage | 2 | 2024 | 658 | 0.680 |
Why?
| Faculty, Medical | 3 | 2025 | 263 | 0.680 |
Why?
| Education, Medical | 1 | 2023 | 241 | 0.670 |
Why?
| Hippocampus | 1 | 2024 | 785 | 0.660 |
Why?
| Machine Learning | 1 | 2024 | 417 | 0.660 |
Why?
| Costs and Cost Analysis | 1 | 2020 | 211 | 0.660 |
Why?
| Recovery of Function | 1 | 2023 | 641 | 0.660 |
Why?
| Organizational Policy | 1 | 2020 | 76 | 0.660 |
Why?
| Aortic Valve Stenosis | 5 | 2022 | 291 | 0.650 |
Why?
| Purinergic P2Y Receptor Antagonists | 1 | 2020 | 67 | 0.650 |
Why?
| Respiratory Insufficiency | 2 | 2020 | 316 | 0.650 |
Why?
| Thrombocytopenia | 1 | 2021 | 187 | 0.640 |
Why?
| Rats, Sprague-Dawley | 1 | 2024 | 2308 | 0.640 |
Why?
| Negative-Pressure Wound Therapy | 1 | 2019 | 21 | 0.640 |
Why?
| Electronic Mail | 1 | 2019 | 61 | 0.630 |
Why?
| Patient Transfer | 3 | 2019 | 162 | 0.620 |
Why?
| Students, Medical | 1 | 2023 | 305 | 0.620 |
Why?
| Tracheostomy | 1 | 2020 | 119 | 0.610 |
Why?
| General Surgery | 3 | 2015 | 156 | 0.600 |
Why?
| Shock, Septic | 1 | 2020 | 204 | 0.580 |
Why?
| Adult | 23 | 2024 | 35361 | 0.550 |
Why?
| Educational Measurement | 2 | 2019 | 259 | 0.550 |
Why?
| Surgical Wound Infection | 2 | 2023 | 291 | 0.550 |
Why?
| Clinical Decision-Making | 1 | 2019 | 311 | 0.540 |
Why?
| Aspirin | 1 | 2020 | 379 | 0.540 |
Why?
| Survival Rate | 8 | 2024 | 1884 | 0.530 |
Why?
| Risk Assessment | 12 | 2023 | 3286 | 0.520 |
Why?
| Platelet Aggregation Inhibitors | 1 | 2020 | 453 | 0.510 |
Why?
| Patient Reported Outcome Measures | 1 | 2019 | 359 | 0.500 |
Why?
| Lung Transplantation | 2 | 2018 | 276 | 0.490 |
Why?
| Stroke | 1 | 2024 | 1111 | 0.480 |
Why?
| Transportation of Patients | 1 | 2015 | 50 | 0.460 |
Why?
| Extracorporeal Circulation | 1 | 2014 | 15 | 0.460 |
Why?
| Factor Analysis, Statistical | 1 | 2015 | 284 | 0.450 |
Why?
| Pulsatile Flow | 1 | 2014 | 60 | 0.450 |
Why?
| Sepsis | 1 | 2020 | 561 | 0.440 |
Why?
| Anticoagulants | 4 | 2023 | 622 | 0.430 |
Why?
| Hemodynamics | 3 | 2022 | 1095 | 0.430 |
Why?
| Biomarkers | 1 | 2024 | 3874 | 0.430 |
Why?
| Reoperation | 4 | 2022 | 555 | 0.420 |
Why?
| Tertiary Care Centers | 1 | 2014 | 147 | 0.420 |
Why?
| Jugular Veins | 1 | 2013 | 39 | 0.420 |
Why?
| Specialties, Surgical | 1 | 2014 | 77 | 0.420 |
Why?
| Education, Medical, Continuing | 1 | 2014 | 123 | 0.420 |
Why?
| Vasodilator Agents | 1 | 2015 | 325 | 0.410 |
Why?
| Aortic Aneurysm | 1 | 2013 | 64 | 0.410 |
Why?
| Internationality | 1 | 2013 | 148 | 0.410 |
Why?
| Myocardial Ischemia | 1 | 2014 | 254 | 0.400 |
Why?
| Decision Making | 1 | 2019 | 837 | 0.390 |
Why?
| Aorta, Thoracic | 1 | 2014 | 260 | 0.380 |
Why?
| Propensity Score | 3 | 2024 | 262 | 0.380 |
Why?
| Thromboembolism | 1 | 2012 | 105 | 0.380 |
Why?
| Acute Disease | 5 | 2024 | 978 | 0.370 |
Why?
| Esophagectomy | 1 | 2012 | 122 | 0.370 |
Why?
| Patient Positioning | 2 | 2021 | 51 | 0.350 |
Why?
| Preoperative Care | 1 | 2012 | 343 | 0.340 |
Why?
| Oxygen | 1 | 2015 | 912 | 0.340 |
Why?
| United States | 10 | 2025 | 13975 | 0.340 |
Why?
| Sarcopenia | 2 | 2024 | 73 | 0.340 |
Why?
| Nitric Oxide | 1 | 2015 | 892 | 0.330 |
Why?
| Cardiologists | 2 | 2019 | 46 | 0.320 |
Why?
| Cardiopulmonary Resuscitation | 2 | 2024 | 258 | 0.320 |
Why?
| Odds Ratio | 2 | 2023 | 1019 | 0.310 |
Why?
| Esophageal Neoplasms | 1 | 2012 | 297 | 0.310 |
Why?
| Frailty | 2 | 2024 | 148 | 0.300 |
Why?
| Preoperative Period | 3 | 2019 | 112 | 0.290 |
Why?
| Transcatheter Aortic Valve Replacement | 2 | 2022 | 168 | 0.290 |
Why?
| Hypoxia | 1 | 2015 | 1070 | 0.290 |
Why?
| Severity of Illness Index | 6 | 2020 | 2767 | 0.280 |
Why?
| Academic Medical Centers | 2 | 2020 | 473 | 0.270 |
Why?
| Survival Analysis | 4 | 2019 | 1282 | 0.270 |
Why?
| Bioprosthesis | 3 | 2022 | 40 | 0.270 |
Why?
| Tissue Donors | 2 | 2020 | 398 | 0.260 |
Why?
| Acute Kidney Injury | 2 | 2025 | 786 | 0.260 |
Why?
| Minimally Invasive Surgical Procedures | 3 | 2024 | 172 | 0.260 |
Why?
| Partial Thromboplastin Time | 2 | 2023 | 54 | 0.250 |
Why?
| Incidence | 5 | 2025 | 2634 | 0.250 |
Why?
| Physicians | 1 | 2014 | 846 | 0.250 |
Why?
| Patient Selection | 2 | 2019 | 671 | 0.250 |
Why?
| Michigan | 3 | 2017 | 105 | 0.250 |
Why?
| Perfusion | 2 | 2018 | 191 | 0.240 |
Why?
| Mitral Valve | 3 | 2024 | 101 | 0.240 |
Why?
| Radial Artery | 1 | 2025 | 68 | 0.230 |
Why?
| Heart Septal Defects, Ventricular | 1 | 2024 | 42 | 0.230 |
Why?
| Blood Transfusion | 2 | 2024 | 294 | 0.230 |
Why?
| Lung Injury | 2 | 2017 | 214 | 0.230 |
Why?
| Phlebotomy | 1 | 2024 | 17 | 0.220 |
Why?
| Systemic Inflammatory Response Syndrome | 1 | 2024 | 84 | 0.220 |
Why?
| Logistic Models | 4 | 2023 | 1963 | 0.220 |
Why?
| Social Class | 2 | 2023 | 256 | 0.220 |
Why?
| Factor IX | 1 | 2023 | 36 | 0.220 |
Why?
| Random Allocation | 1 | 2024 | 351 | 0.220 |
Why?
| Iatrogenic Disease | 1 | 2024 | 57 | 0.220 |
Why?
| Catheterization | 2 | 2024 | 176 | 0.220 |
Why?
| Factor VIIa | 1 | 2023 | 38 | 0.220 |
Why?
| Blood Coagulation Factors | 1 | 2023 | 47 | 0.220 |
Why?
| Renal Replacement Therapy | 1 | 2023 | 88 | 0.210 |
Why?
| Hospitals, Low-Volume | 1 | 2023 | 23 | 0.210 |
Why?
| Publishing | 1 | 2025 | 139 | 0.210 |
Why?
| Hospitals, High-Volume | 1 | 2023 | 40 | 0.210 |
Why?
| Follow-Up Studies | 5 | 2019 | 4917 | 0.210 |
Why?
| Disease Models, Animal | 4 | 2024 | 3994 | 0.210 |
Why?
| Prognosis | 6 | 2020 | 3787 | 0.200 |
Why?
| Coronary Angiography | 1 | 2025 | 341 | 0.200 |
Why?
| Mentors | 2 | 2021 | 174 | 0.200 |
Why?
| Acute Lung Injury | 2 | 2018 | 278 | 0.200 |
Why?
| Morbidity | 2 | 2020 | 301 | 0.200 |
Why?
| Cost Savings | 1 | 2022 | 82 | 0.200 |
Why?
| Contrast Media | 1 | 2025 | 387 | 0.200 |
Why?
| Pacemaker, Artificial | 2 | 2020 | 115 | 0.200 |
Why?
| Tricuspid Valve | 2 | 2022 | 28 | 0.200 |
Why?
| Schools, Medical | 1 | 2023 | 128 | 0.200 |
Why?
| Surgical Drapes | 1 | 2021 | 2 | 0.190 |
Why?
| Medical Illustration | 1 | 2021 | 9 | 0.190 |
Why?
| Punctures | 1 | 2021 | 40 | 0.190 |
Why?
| Kaplan-Meier Estimate | 4 | 2019 | 861 | 0.190 |
Why?
| Renal Insufficiency | 1 | 2023 | 150 | 0.190 |
Why?
| Work-Life Balance | 1 | 2021 | 17 | 0.190 |
Why?
| Bandages | 1 | 2021 | 34 | 0.190 |
Why?
| Suction | 1 | 2021 | 32 | 0.190 |
Why?
| United Kingdom | 1 | 2022 | 263 | 0.190 |
Why?
| Practice Guidelines as Topic | 2 | 2020 | 1523 | 0.190 |
Why?
| Interleukin-8 | 1 | 2022 | 261 | 0.190 |
Why?
| Dilatation | 1 | 2021 | 62 | 0.180 |
Why?
| Antineoplastic Agents | 1 | 2012 | 2038 | 0.180 |
Why?
| Socioeconomic Factors | 2 | 2022 | 1192 | 0.180 |
Why?
| Cohort Studies | 6 | 2020 | 5394 | 0.180 |
Why?
| Blood Coagulation | 1 | 2022 | 228 | 0.180 |
Why?
| Heart Block | 1 | 2020 | 41 | 0.180 |
Why?
| Checklist | 1 | 2021 | 99 | 0.180 |
Why?
| Vagus Nerve Injuries | 1 | 2020 | 2 | 0.180 |
Why?
| Disinfection | 1 | 2021 | 116 | 0.170 |
Why?
| Informed Consent | 1 | 2021 | 180 | 0.170 |
Why?
| Coronary Artery Bypass, Off-Pump | 1 | 2020 | 16 | 0.170 |
Why?
| Recombinant Proteins | 1 | 2023 | 1304 | 0.170 |
Why?
| Societies, Medical | 1 | 2024 | 760 | 0.170 |
Why?
| Swine | 3 | 2022 | 740 | 0.170 |
Why?
| Donor Selection | 1 | 2020 | 74 | 0.170 |
Why?
| Renal Dialysis | 1 | 2023 | 417 | 0.170 |
Why?
| Vagus Nerve | 1 | 2020 | 85 | 0.170 |
Why?
| Teaching | 1 | 2021 | 209 | 0.160 |
Why?
| Cardiac Catheterization | 1 | 2023 | 583 | 0.160 |
Why?
| Adenosine A2 Receptor Agonists | 1 | 2019 | 20 | 0.160 |
Why?
| Health Care Costs | 2 | 2020 | 404 | 0.160 |
Why?
| Learning Curve | 1 | 2019 | 68 | 0.160 |
Why?
| Echocardiography, Transesophageal | 1 | 2019 | 104 | 0.160 |
Why?
| Research Support as Topic | 1 | 2019 | 113 | 0.150 |
Why?
| Biological Products | 1 | 2022 | 202 | 0.150 |
Why?
| Lipopolysaccharides | 1 | 2022 | 877 | 0.150 |
Why?
| Warm Ischemia | 1 | 2018 | 12 | 0.150 |
Why?
| Psoas Muscles | 1 | 2018 | 8 | 0.150 |
Why?
| Prosthesis Fitting | 1 | 2018 | 16 | 0.150 |
Why?
| Gastrointestinal Diseases | 1 | 2020 | 197 | 0.150 |
Why?
| Cardiac Valve Annuloplasty | 1 | 2017 | 2 | 0.150 |
Why?
| Heart Failure, Systolic | 1 | 2018 | 25 | 0.150 |
Why?
| Protective Agents | 1 | 2018 | 38 | 0.150 |
Why?
| Sphingosine | 1 | 2018 | 39 | 0.150 |
Why?
| Leadership | 1 | 2021 | 356 | 0.140 |
Why?
| Coronary Disease | 1 | 2020 | 389 | 0.140 |
Why?
| Lysophospholipids | 1 | 2018 | 71 | 0.140 |
Why?
| Cardiac Pacing, Artificial | 1 | 2018 | 82 | 0.140 |
Why?
| Aortic Aneurysm, Thoracic | 1 | 2019 | 128 | 0.140 |
Why?
| Patient Readmission | 1 | 2023 | 674 | 0.140 |
Why?
| Workload | 2 | 2019 | 154 | 0.140 |
Why?
| Drug Therapy, Combination | 1 | 2020 | 1020 | 0.140 |
Why?
| Skin | 1 | 2021 | 737 | 0.130 |
Why?
| Reperfusion Injury | 1 | 2019 | 274 | 0.130 |
Why?
| Intubation, Intratracheal | 1 | 2018 | 241 | 0.130 |
Why?
| Kidney | 1 | 2023 | 1330 | 0.130 |
Why?
| Stents | 1 | 2020 | 518 | 0.130 |
Why?
| Kidney Transplantation | 1 | 2023 | 638 | 0.130 |
Why?
| Rats | 1 | 2024 | 5236 | 0.130 |
Why?
| Animals | 6 | 2024 | 34628 | 0.130 |
Why?
| Guideline Adherence | 1 | 2020 | 526 | 0.120 |
Why?
| Hepatectomy | 1 | 2016 | 205 | 0.120 |
Why?
| Partial Pressure | 1 | 2015 | 29 | 0.120 |
Why?
| Formative Feedback | 1 | 2015 | 26 | 0.120 |
Why?
| Hospitals | 1 | 2020 | 628 | 0.120 |
Why?
| Patient Care Team | 1 | 2020 | 605 | 0.120 |
Why?
| Comorbidity | 1 | 2020 | 1542 | 0.120 |
Why?
| Blood Gas Analysis | 1 | 2015 | 71 | 0.120 |
Why?
| Equipment Design | 1 | 2016 | 522 | 0.120 |
Why?
| Staff Development | 1 | 2015 | 56 | 0.120 |
Why?
| Analgesics, Opioid | 1 | 2022 | 914 | 0.120 |
Why?
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 1060 | 0.110 |
Why?
| Myxoma | 1 | 2014 | 12 | 0.110 |
Why?
| Practice Patterns, Physicians' | 2 | 2020 | 1281 | 0.110 |
Why?
| Pandemics | 1 | 2023 | 1516 | 0.110 |
Why?
| Inflammation | 1 | 2024 | 2694 | 0.110 |
Why?
| Heart Neoplasms | 1 | 2014 | 50 | 0.110 |
Why?
| Administration, Inhalation | 1 | 2015 | 675 | 0.100 |
Why?
| Echocardiography, Doppler | 1 | 2014 | 111 | 0.100 |
Why?
| Hemolysis | 1 | 2014 | 199 | 0.100 |
Why?
| Chemoradiotherapy, Adjuvant | 1 | 2012 | 41 | 0.100 |
Why?
| Primary Prevention | 1 | 2014 | 191 | 0.100 |
Why?
| Body Mass Index | 1 | 2020 | 2244 | 0.100 |
Why?
| Mental Disorders | 1 | 2020 | 1024 | 0.090 |
Why?
| Sheep | 1 | 2014 | 832 | 0.090 |
Why?
| Aorta | 1 | 2014 | 410 | 0.090 |
Why?
| Surgical Procedures, Operative | 1 | 2014 | 249 | 0.090 |
Why?
| Data Collection | 1 | 2014 | 652 | 0.090 |
Why?
| Recurrence | 1 | 2014 | 1013 | 0.090 |
Why?
| Respiration, Artificial | 1 | 2015 | 594 | 0.090 |
Why?
| Anti-Bacterial Agents | 1 | 2020 | 1701 | 0.090 |
Why?
| Thoracotomy | 2 | 2022 | 75 | 0.090 |
Why?
| Lung Neoplasms | 1 | 2023 | 2353 | 0.080 |
Why?
| Neoadjuvant Therapy | 1 | 2012 | 383 | 0.080 |
Why?
| Echocardiography | 3 | 2018 | 634 | 0.080 |
Why?
| Diagnosis, Differential | 1 | 2013 | 1435 | 0.080 |
Why?
| Lung | 2 | 2022 | 3925 | 0.080 |
Why?
| Myocardium | 1 | 2014 | 981 | 0.080 |
Why?
| Heart Ventricles | 1 | 2014 | 778 | 0.080 |
Why?
| Obesity | 1 | 2020 | 2844 | 0.070 |
Why?
| Algorithms | 1 | 2015 | 1626 | 0.070 |
Why?
| Blood Pressure | 1 | 2014 | 1743 | 0.070 |
Why?
| Tomography, X-Ray Computed | 1 | 2016 | 2530 | 0.070 |
Why?
| Multivariate Analysis | 2 | 2021 | 1504 | 0.070 |
Why?
| Publications | 1 | 2025 | 42 | 0.060 |
Why?
| Efficiency | 1 | 2025 | 95 | 0.060 |
Why?
| Mediastinum | 1 | 2023 | 23 | 0.050 |
Why?
| Unemployment | 1 | 2023 | 42 | 0.050 |
Why?
| Aged, 80 and over | 3 | 2020 | 7050 | 0.050 |
Why?
| Tidal Volume | 1 | 2022 | 83 | 0.050 |
Why?
| Ventilators, Mechanical | 1 | 2022 | 58 | 0.050 |
Why?
| Lymph Node Excision | 1 | 2023 | 166 | 0.050 |
Why?
| Cluster Analysis | 1 | 2023 | 479 | 0.050 |
Why?
| Surveys and Questionnaires | 1 | 2014 | 5355 | 0.050 |
Why?
| Prospective Studies | 1 | 2013 | 7060 | 0.050 |
Why?
| Antibodies | 1 | 2023 | 392 | 0.050 |
Why?
| Employment | 1 | 2023 | 161 | 0.050 |
Why?
| Travel | 1 | 2021 | 123 | 0.040 |
Why?
| Predictive Value of Tests | 2 | 2018 | 1967 | 0.040 |
Why?
| Quality Indicators, Health Care | 1 | 2023 | 299 | 0.040 |
Why?
| Quality-Adjusted Life Years | 1 | 2020 | 116 | 0.040 |
Why?
| Lymph Nodes | 1 | 2023 | 458 | 0.040 |
Why?
| Pain, Postoperative | 1 | 2022 | 227 | 0.040 |
Why?
| Erythrocyte Transfusion | 1 | 2022 | 185 | 0.040 |
Why?
| Ligands | 1 | 2022 | 614 | 0.040 |
Why?
| Acetaminophen | 1 | 2022 | 255 | 0.040 |
Why?
| Toll-Like Receptor 4 | 1 | 2022 | 294 | 0.040 |
Why?
| Pain Management | 1 | 2022 | 319 | 0.040 |
Why?
| Neoplasm Staging | 1 | 2023 | 1285 | 0.040 |
Why?
| Heart | 1 | 2023 | 650 | 0.040 |
Why?
| North Carolina | 1 | 2018 | 91 | 0.040 |
Why?
| Interleukin-6 | 1 | 2022 | 715 | 0.040 |
Why?
| Lung Abscess | 1 | 2018 | 7 | 0.040 |
Why?
| Decompressive Craniectomy | 1 | 2018 | 6 | 0.040 |
Why?
| Empyema, Pleural | 1 | 2018 | 12 | 0.040 |
Why?
| Polytetrafluoroethylene | 1 | 2018 | 24 | 0.040 |
Why?
| Organ Preservation Solutions | 1 | 2018 | 43 | 0.040 |
Why?
| Graft Survival | 1 | 2020 | 523 | 0.040 |
Why?
| Age Factors | 1 | 2025 | 3133 | 0.040 |
Why?
| Educational Status | 1 | 2019 | 458 | 0.030 |
Why?
| Suture Techniques | 1 | 2018 | 120 | 0.030 |
Why?
| Cerebral Hemorrhage | 1 | 2018 | 108 | 0.030 |
Why?
| Death | 1 | 2018 | 124 | 0.030 |
Why?
| Observer Variation | 1 | 2018 | 321 | 0.030 |
Why?
| Administration, Oral | 1 | 2019 | 783 | 0.030 |
Why?
| Organ Size | 1 | 2018 | 446 | 0.030 |
Why?
| Myocarditis | 1 | 2018 | 101 | 0.030 |
Why?
| Endothelial Cells | 1 | 2022 | 734 | 0.030 |
Why?
| Needs Assessment | 1 | 2018 | 360 | 0.030 |
Why?
| Cause of Death | 1 | 2017 | 392 | 0.030 |
Why?
| Consensus | 1 | 2019 | 644 | 0.030 |
Why?
| Atrial Fibrillation | 1 | 2019 | 370 | 0.030 |
Why?
| Dose-Response Relationship, Drug | 1 | 2019 | 1968 | 0.030 |
Why?
| Vaccination | 1 | 2023 | 1350 | 0.030 |
Why?
| Stroke Volume | 1 | 2018 | 587 | 0.030 |
Why?
| Proportional Hazards Models | 1 | 2017 | 1221 | 0.030 |
Why?
| Prevalence | 1 | 2020 | 2540 | 0.030 |
Why?
| Longitudinal Studies | 1 | 2020 | 2668 | 0.030 |
Why?
| Curriculum | 1 | 2019 | 925 | 0.030 |
Why?
| Emergency Medical Services | 1 | 2019 | 562 | 0.020 |
Why?
| Case-Control Studies | 1 | 2020 | 3334 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2016 | 1840 | 0.020 |
Why?
| Fellowships and Scholarships | 1 | 2015 | 271 | 0.020 |
Why?
| Quality of Life | 1 | 2023 | 2706 | 0.020 |
Why?
| Child | 2 | 2022 | 20824 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2016 | 3042 | 0.020 |
Why?
| Mice, Inbred C57BL | 1 | 2018 | 5270 | 0.020 |
Why?
| Hospitalization | 1 | 2016 | 2080 | 0.020 |
Why?
| Infant, Newborn | 1 | 2014 | 5704 | 0.010 |
Why?
| Magnetic Resonance Imaging | 1 | 2014 | 3348 | 0.010 |
Why?
| Mice | 1 | 2018 | 16543 | 0.010 |
Why?
| Infant | 1 | 2014 | 8994 | 0.010 |
Why?
| Child, Preschool | 1 | 2014 | 10457 | 0.010 |
Why?
| Young Adult | 1 | 2014 | 12286 | 0.010 |
Why?
| Adolescent | 1 | 2014 | 20197 | 0.010 |
Why?
|
|
Teman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|